Ikena Oncology earnings were -$49.2M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. The latest IKNA earnings report on Dec 31, 2024 announced Q4 2024 earnings of -$9.1M, down 10.8% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, IKNA reported annual earnings of -$49.2M, with -27.8% growth. The next IKNA earnings date is Jun 6, 2025.
On IKNA's earnings call on Invalid Date, Ikena Oncology (NASDAQ: IKNA) reported Q4 2024 earnings per share (EPS) of -$0.19, up 52.5% year over year. Total IKNA earnings for the quarter were -$9.12 million. In the same quarter last year, Ikena Oncology's earnings per share (EPS) was -$0.40.
The next IKNA earnings call is Invalid Date. Add IKNA to your watchlist to be reminded of Ikena Oncology's next earnings date.
Is Ikena Oncology profitable or losing money?
As of the last Ikena Oncology earnings report, Ikena Oncology is currently losing money. Ikena Oncology's net profit (also called net income) for the twelve months ending Dec 31, 2024 was -$49.23 million, a 27.77% decrease year over year.
What was IKNA's earnings growth in the past year?
As of Ikena Oncology's earnings date in Invalid Date, Ikena Oncology's earnings has grown year over year. IKNA earnings in the past year totalled -$49.23 million.
What are Ikena Oncology's earnings expectations?
The current EPS estimate for Ikena Oncology's earnings report in Invalid Date is -$0.41.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.